Subrahmanya Vallabhapurapu
University of Pittsburgh(US)University of Cincinnati Medical Center(US)
Publications by Year
Research Areas
Phagocytosis and Immune Regulation, PI3K/AKT/mTOR signaling in cancer, Protein Degradation and Inhibitors, Renal and related cancers, Autophagy in Disease and Therapy
Most-Cited Works
- → Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium(2015)118 cited
- → Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1(2013)106 cited
- → Transcriptional repression by the HDAC4–RelB–p52 complex regulates multiple myeloma survival and growth(2015)60 cited
- → Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors(2014)54 cited
- → Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells(2014)42 cited
- → PU.1 is regulated by NF-κB through a novel binding site in a 17 kb upstream enhancer element(2009)39 cited
- → Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity(2020)30 cited
- → Transcriptional Repression of Bim by a Novel YY1-RelA Complex Is Essential for the Survival and Growth of Multiple Myeloma(2013)29 cited
- → Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles(2019)27 cited
- → Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer(2020)23 cited